Telmisartan Export Market Intelligence: India's 413 Suppliers Shipping to 132 Countries — TransData Nexus 2026

Q: Who are the top telmisartan exporters from India?

The top telmisartan exporters from India are: 1. CIPLA LIMITED — $10.8B (98.4% market share); 2. MYLAN LABORATORIES LIMITED — $61.5M (0.6% market share); 3. INTAS PHARMACEUTICALS LIMITED — $15.5M (0.1% market share); 4. ARISTO PHARMACEUTICALS PRIVATE LIMITED — $11.6M (0.1% market share); 5. ALEMBIC PHARMACEUTICALS LIMITED — $11.0M (0.1% market share). Together they account for 99.3% of India's total telmisartan export value.

Q: What is the total export value of telmisartan from India?

The total export value of telmisartan from India is $11.0B USD, recorded across 11,086 shipment transactions from 413 active exporters to 132 destination countries. The average shipment value is $990.0K.

Q: Which countries import telmisartan from India?

India exports telmisartan to 132 countries worldwide. The top importing countries are: GERMANY (98.4% share, $10.8B), HUNGARY (0.5% share, $50.5M), UNITED STATES (0.2% share, $26.6M), UGANDA (0.1% share, $11.8M), PHILIPPINES (0.1% share, $10.1M). These five markets account for 99.3% of total export value.

Q: What is the HS code for telmisartan exports from India?

The primary HS code for telmisartan exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of telmisartan exports from India?

The average unit price for telmisartan exports from India is $5.49 USD per unit, with prices ranging from $0.00 to $5219.14 depending on formulation, packaging, and order volume. The total market is valued at $11.0B across 11,086 shipments.

Q: Which ports handle telmisartan exports from India?

The primary ports for telmisartan exports from India are SAHAR AIR CARGO ACC (INBOM4) (15.9% of shipments), SAHAR AIR (15.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (9.0% of shipments), NHAVA SHEVA SEA (INNSA1) (6.8% of shipments), DELHI AIR (5.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of telmisartan?

India is one of the world's leading exporters of telmisartan due to its large base of 413 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports telmisartan to 132 countries, demonstrating 68% global market coverage.

Q: What certifications do Indian telmisartan exporters need?

Indian telmisartan exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import telmisartan from India?

There are 1,116 registered buyers importing telmisartan from India, spread across 132 countries. The repeat buyer rate is 72.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top telmisartan supplier from India?

CIPLA LIMITED is the leading telmisartan exporter from India with a market share of 98.4% and total export value of $10.8B across 1619 shipments. The top 5 suppliers together control 99.3% of total export value.

Suresh Sormare

Telmisartan

India Pharmaceutical Trade Intelligence

$11.0B413 Suppliers132 CountriesHS 30049079

ExportsIndia → GERMANY98.4%India → HUNGARY0.5%

ImportsGERMANY → India$1.9B MALTA → India$18.5M

#1 Supplier: CIPLA LIMITED #1 Buyer: B LOGISTIK

Telmisartan Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Telmisartan to the World

Between 2022 and 2026, India exported $11.0B worth of telmisartan across 11,086 verified shipments to 132 countries — covering 68% of world markets in the Cardiovascular segment. The largest destination is GERMANY (98.4%). CIPLA LIMITED leads with a 98.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·HS 30049079

Telmisartan export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Telmisartan export data snapshot — $11.0B · 413 exporters · 132 countriesTransData Nexus · Indian Customs Data

Top Telmisartan Exporters from India

413 active exporters · Ranked by export value

View all 413 →

Top Telmisartan Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$10.8B	1,619	5	98.4%
2	MYLAN LABORATORIES LIMITED

Top Countries Importing Telmisartan from India

132 destination markets · Ranked by import value

All 132 countries →

Top Countries Importing Telmisartan from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	GERMANY	$10.8B	98.4%
2	HUNGARY	$50.5M	0.5%
3	UNITED STATES	$26.6M	0.2%
4	UGANDA	$11.8M	0.1%
5	PHILIPPINES	$10.1M	0.1%
6	CHILE	$9.3M	0.1%
7	SRI LANKA	$8.2M	0.1%
8	AUSTRALIA	$7.9M	0.1%
9	MEXICO	$5.4M	0.0%
10	COLOMBIA	$3.7M	0.0%

GERMANY is India's largest telmisartan export destination, absorbing 98.4% of total exports worth $10.8B. The top 5 importing countries — GERMANY, HUNGARY, UNITED STATES, UGANDA, PHILIPPINES — together account for 99.3% of India's total telmisartan export value. The remaining 127 destination countries collectively receive the other 0.7%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Telmisartan to India?

26 origin countries · Total import value: $1.9B

India imports telmisartan from 26 countries with a combined import value of $1.9B. The largest supplier is GERMANY ($1.9B, 119 shipments), followed by MALTA and SPAIN. All values are from Indian Customs (DGFT) import records.

Countries Supplying Telmisartan to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$1.9B	119	98.9%
2	MALTA	$18.5M	56	1.0%
3	SPAIN	$1.8M	6	0.1%
4	CHINA	$263.0K	8	0.0%
5	UNITED STATES	$216.4K	157	0.0%
6	BRAZIL	$22.6K	14	0.0%
7	HUNGARY	$11.4K	28	0.0%
8	FINLAND	$8.8K	4	0.0%
9	CANADA	$7.3K	31	0.0%
10	UNITED KINGDOM	$7.2K	10	0.0%

Showing top 10 of 26 origin countries

GERMANY is the largest supplier of telmisartan to India, accounting for 98.9% of total import value. The top 5 origin countries — GERMANY, MALTA, SPAIN, CHINA, UNITED STATES — together supply 100.0% of India's telmisartan imports. Click any country to see detailed supplier and buyer data for that import corridor.

Telmisartan — Export Intelligence Video

Visual overview of India's telmisartan import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's telmisartan pharmaceutical import and export market — $11.0B in total trade, 413 verified manufacturers, and 132 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Telmisartan

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, telmisartan is approved for the treatment of hypertension and to reduce cardiovascular risk. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for telmisartan, indicating a competitive generic market. Notably, the FDA approved an ANDA for telmisartan tablets by Aurobindo Pharma Limited in March 2025. As of March 2026, there are no active import alerts related to telmisartan, facilitating its importation into the U.S. market. The substantial number of Indian exporters (413) underscores India's significant role in supplying telmisartan to the U.S., reflecting the country's robust pharmaceutical manufacturing capabilities.

2EU & UK Regulatory Framework

In the European Union, telmisartan is authorized for treating essential hypertension and reducing cardiovascular morbidity. The European Medicines Agency (EMA) has approved various telmisartan-containing products, including generics like Telmisartan Actavis, authorized on 30 September 2010. However, on 19 May 2021, the European Commission withdrew the marketing authorization for Telmisartan Teva at the request of the marketing authorization holder, Teva B.V., due to commercial reasons. The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) continues to regulate telmisartan post-Brexit, adhering to standards comparable to the EMA's. Compliance with EU Good Manufacturing Practice (GMP) requirements is mandatory for manufacturers exporting telmisartan to these markets.

3WHO Essential Medicines & Global Standards

Telmisartan is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in managing hypertension globally. The WHO Prequalification Programme has assessed and prequalified certain telmisartan products, ensuring they meet international quality standards. Telmisartan's specifications are detailed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), providing standardized quality benchmarks for its production and quality control.

4India Regulatory Classification

In India, telmisartan is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for telmisartan tablets to ensure affordability; the latest revision was in August 2025. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products; however, telmisartan is generally exempt from this requirement, facilitating its export process.

5Patent & Exclusivity Status

The primary patents for telmisartan have expired, leading to a competitive generic market with multiple manufacturers producing and exporting the drug. This has resulted in increased availability and reduced prices globally, benefiting healthcare systems and patients.

6Recent Industry Developments

In June 2025, the NPPA revised the ceiling price for telmisartan tablets, reducing it by 5% to enhance affordability. In September 2025, the EMA approved a new fixed-dose combination of telmisartan and amlodipine for hypertension treatment, expanding therapeutic options. In December 2025, the WHO updated its Model List of Essential Medicines, reaffirming telmisartan's inclusion, highlighting its continued relevance in global health. In February 2026, the CDSCO issued new guidelines for the bioequivalence studies of telmisartan, aiming to ensure consistent quality among generics. In March 2026, the FDA conducted inspections of Indian manufacturing facilities producing telmisartan, emphasizing compliance with GMP standards.

These developments reflect ongoing efforts by regulatory authorities to ensure the quality, safety, and affordability of telmisartan, reinforcing its critical role in managing hypertension worldwide.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Telmisartan

Retail & reference prices across 9 markets vs. India FOB export price of $5.49/unit

Global Price Benchmark for Telmisartan across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	The FDA Orange Book lists approved Telmisartan products but does not provide pricing information.
United Kingdom	N/A	GBP	The NHS Drug Tariff provides pricing for medications; however, specific pricing for Telmisartan is not readily accessible.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceuticals, but specific pricing data for Telmisartan is not publicly available.
Australia	N/A

Supply Chain Risk Assessment — Telmisartan

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Telmisartan, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. As of 2019, approximately 68% of India's API imports originated from China, highlighting a significant dependency on Chinese suppliers. This reliance exposes the supply chain to risks associated with geopolitical tensions, trade restrictions, and environmental regulations affecting Chinese manufacturing.

In response, the Indian government launched the Production Linked Incentive (PLI) scheme in 2020, aiming to bolster domestic API and KSM production. By November 2024, this initiative led to the inauguration of two greenfield plants dedicated to manufacturing critical molecules like Penicillin G and Clavulanic Acid, essential for antibiotic production. These efforts are projected to reduce India's import dependence on key pharmaceutical ingredients by half. However, the transition to self-sufficiency is ongoing, and the industry remains vulnerable to external supply disruptions in the interim.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals a high supplier concentration in Telmisartan exports from India. The top five exporters account for 99.3% of the total export value, with CIPLA LIMITED alone contributing 98.4% ($10,800.1 million USD). This dominance indicates a significant single-source risk, as any operational or regulatory issues affecting CIPLA LIMITED could severely disrupt the global supply of Telmisartan.

Access Complete Telmisartan Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 11,086 transactions across 132 markets.

Request Demo View Pricing

Frequently Asked Questions — Telmisartan Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top telmisartan exporters from India?

The leading telmisartan exporters from India are CIPLA LIMITED, MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, and 12 others. CIPLA LIMITED leads with 98.4% market share ($10.8B). The top 5 suppliers together control 99.3% of total export value.

What is the total export value of telmisartan from India?

The total export value of telmisartan from India is $11.0B, recorded across 11,086 shipments from 413 active exporters to 132 countries. The average shipment value is $990.0K.

Which countries import telmisartan from India?

India exports telmisartan to 132 countries. The top importing countries are GERMANY (98.4%), HUNGARY (0.5%), UNITED STATES (0.2%), UGANDA (0.1%), PHILIPPINES (0.1%), which together account for 99.3% of total export value.

What is the HS code for telmisartan exports from India?

The primary HS code for telmisartan exports from India is 30049079. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Telmisartan

Telmisartan

Top Telmisartan Exporters from India

Top Countries Importing Telmisartan from India

Who Supplies Telmisartan to India?

Quick Facts

Related Cardiovascular

Related Analysis

Need Details?

Telmisartan — Export Intelligence Video

Regulatory Landscape — Telmisartan

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Telmisartan

Supply Chain Risk Assessment — Telmisartan

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Telmisartan Trade Intelligence

Frequently Asked Questions — Telmisartan Exports from India

Who are the top telmisartan exporters from India?

What is the total export value of telmisartan from India?

Which countries import telmisartan from India?

What is the HS code for telmisartan exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of telmisartan exports from India?

Which ports handle telmisartan exports from India?

Why is India a leading exporter of telmisartan?

What certifications do Indian telmisartan exporters need?

How many buyers import telmisartan from India?

What is the market share of the top telmisartan exporter from India?

Analysis Methodology